Antiepileptic drugs

Farmaci antiepilettici, vitamina D e mineralizzazione ossea: le evidenze e le azioni

Troisi A, Lama C, Iacono A, Ricciardelli P, Marchetti F

2021/4 — pag. 258-260 — DOI

The possible negative effects of antiepileptic drugs on bone metabolism with the consequent possible risks have been discussed in the literature for more than 30 years. Two reviews of the literature attempted to answer the following clinical question...

Farmaci antiepilettici, vitamina D e mineralizzazione ossea: le evidenze e le azioni

Troisi A, Lama C, Iacono A, Ricciardelli P, Marchetti F

2021/4 — pag. 124-128 — DOI

The possible negative effects of antiepileptic drugs on bone metabolism with the consequent possible risks have been discussed in the literature for more than 30 years. Two reviews of the literature attempted to answer the following clinical question...

Le crisi convulsive post-traumatiche

A. Canuto

2018/10

Anticorpi anti-istone: è sempre lupus indotto da farmaci?

A. Azzali, T. Giani, G. Simonini, R. Cimaz

2018/2 — pag. 119-122

The paper describes the case of a South-American 14-year-old girl who presented with arthralgia, weakness and alopecia. As she was under antiepileptic treatment since she was 5 years of age, on suspicion of drug-induced lupus erythematosus (DILE) ant...

Anticorpi anti-istone: è sempre lupus indotto da farmaci?

A. Azzali, T. Giani, G. Simonini, R. Cimaz

2018/2

The paper describes the case of a South-American 14-year-old girl who presented with arthralgia, weakness and alopecia. As she was under antiepileptic treatment since she was 5 years of age, on suspicion of drug-induced lupus erythematosus (DILE) ant...

Antiepilettici e allattamento al seno

S. Dal Bo, L. Matarazzo, R. Davanzo

2011/6 — pag. 384-386

Breastfeeding mothers treated for epilepsia face the conflict of interest between their health and the lactational risk for the nursing infant. According to our review, only ethosuximide and zonisamide are contraindicated. Indeed, the great majority ...

L'epilessia (iii° parte)

M. Lazzerini

2004/7

Rischio dermatologico dopo trattamento con antiepilettici

G. Bartolozzi

1999/9